Search Results By Date:
Showing 1 - 15 of 621 results
  • Mbatidde L, Thaliath L, Ethington EG, Cutlan JE, Onitilo AA. An Atypical Case of Exophiala Bergeri Chromoblastomycosis in an Immunosuppromised Individual. Clin Med Res. 2025 November 23;23(3):125-128. doi: 10.3121/cmr.2025.2044.
    PubMed ID: 41285445
  • Abdulmajeed J, Shi Z, Abdel-Rahman ME, Shahid F, Alam MF, Al-Shafai M,...Doi SA [including Onitilo AA.] Bariatric metabolic surgery and cancer risk: Target trial emulation using iterative time distribution matching. [published online ahead of print 2025 November 11]. Biomol Biomed. doi: 10.17305/bb.2025.12842.
    PubMed ID: 41217501
  • Mbatidde L, Sharma R, Michalske MJ, Chalia J, Onitilo AA. High-Grade Angiosarcoma Transformation in Schwannoma and SMARCB1 Mutation: A Case Report. American Journal of Case Reports. 2025 October 21;26. doi: 10.12659/AJCR.947742. PMCID: PMC12553317.
    PubMed ID: 41116620
  • Wen Z, Wang Y, Fox KC, Bissonnette AM, Moat LF, Kitchner TE,...Onitilo AA [including Hebbring SJ.] Inhibition of FOXM1 Synergizes with BH3 Mimetics Venetoclax and Sonrotoclax in Killing Multiple Myeloma Cells through Repressing MYC Pathway. Adv Sci (Weinh). 2025 October 12;e08822. doi: 10.1002/advs.202508822. PMCID: PMC12499415.
    PubMed ID: 40654055
  • Afolaranmi O, Garton EM, Dada OE, Virani SS, Shour AR, Onitilo AA, Zafar SN. Cancer Research Funding in Africa. Commun Med (Lond). 2025 July 7;5(1):278. doi: 10.1038/s43856-025-00992-7. PMCID: PMC12234859.
    PubMed ID: 40624332
  • Joseph A, Nwachukwu C, Adegboyega B, Salako O, Andero T, Alabi A,...Balogun O [including Puthoff D, Onitilo A.] 3D HDR brachytherapy for cervical cancer in LMIC: Audit of a single institution experience in Lagos, Nigeria. Brachytherapy. 2025 July. doi: 10.1016/j.brachy.2025.01.007.
    PubMed ID: 40300972
  • Unger JM, Andrews HS, Levit LA, McKelvey BA, Stewart M, Canin B,...Schenkel C [including Onitilo A.] Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Treatment Trials: A Meta-Analysis of Industry and National Cancer Institute Studies. JCO Oncol Adv. 2025 June 13;2(1):e2500021. doi: 10.1200/OA-25-00021. PMCID: PMC12178165.
    PubMed ID: 40546794
  • Shour A, Onitilio A. Racial and Ethnic Minority Groups in the Context of Structural Inequalities and Health Outcomes. Structural Inequalities and Health Outcomes for Chronic Disease. Academic Press; 2025: 1.
  • Yerukala Sathipati S, Carter T, Soodi D, Somto N, Shukla SK, Petronovich J,...Sharma P [including Glurich I.] MicroRNA signature predicts post-operative atrial fibrillation after coronary artery bypass grafting. MedRxiv. 2025 May 28;15(1):18658. doi: 10.1101/2024.06.21.24309328. PMCID: PMC12119944.
    PubMed ID: 40436930
  • Baron E, Patterson R, Tillman R, Wernberg JA, Sharma R. Real-world application of Cytalux for targeted imaging of occult peritoneal disease in epithelial ovarian cancer. Mol Clin Oncol. 2025 April 16;22(6):55. doi: 10.3892/mco.2025.2850. PMCID: PMC12035792.
    PubMed ID: 40297499
  • Guenther JM, Ward A, Martin BJ, Cripe M, Beard T, Wisco O,...Yamamoto M [including Sharma R.] A Prospective, Multicenter Analysis of Recurrence-Free Survival After Sentinel Lymph Node Biopsy Decisions Influenced by the 31-GEP. Cancer Med. 2025 April;14(7):e70839. doi: 10.1002/cam4.70839. PMCID: PMC11959192.
    PubMed ID: 40165762
  • Onitilo A, Li YH, Shimpi N, Glurich I, Putthoff D, Shour A,...Melms WF. Service Line Director Appraisal: Evaluating Impact on Provider Satisfaction in a Rural-Based Clinic. WMJ. 2025 April;124(1):47-54.
    PubMed ID: 40262007
  • Joseph A, Balogun O, Adegboyega B, Salako O, Irabor OC, Ajose A,...Nwachukwu C [including Puthoff D, Onitilo A.] Development and implementation of a 3d-HDR brachytherapy program for cervical cancer in a sub-Saharan African centre. Brachytherapy. 2025 March 24;(2):258-264. doi: 10.1016/j.brachy.2024.10.002.
    PubMed ID: 39730268
  • Shour AR, Anguzu R, Onitilo AA. Speech Recognition Technology and Documentation Efficiency. JAMA Netw Open. 2025 March 3;8(3):e251526. doi: 10.1001/jamanetworkopen.2025.1526. PMCID: PMC11934006.
    PubMed ID: 40126483
  • McBane RD, Loprinzi CL, Zemla T, Tafur A, Sanfilippo K, Liu JJ,...Wysokinski WE [including Onitilo AA.] Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714]. J Thromb Haemost. 2025 February;6:1704-1714. doi: 10.1016/j.jtha.2024.12.011.
    PubMed ID: 39709266